Pzena Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $166M | Sell |
5,924,892
-601,908
| -9% | -$16M | 0.54% | 40 |
|
|
2025
Q4 | $163M | Sell |
6,526,800
-88,798
| -1% | -$2.24M | 0.49% | 39 |
|
|
2025
Q3 | $169M | Buy |
6,615,598
+56,484
| +0.9% | +$1.39M | 0.54% | 38 |
|
|
2025
Q2 | $159M | Sell |
6,559,114
-499,867
| -7% | -$11.7M | 0.52% | 38 |
|
|
2025
Q1 | $179M | Buy |
7,058,981
+107,402
| +2% | +$2.81M | 0.62% | 36 |
|
|
2024
Q4 | $184M | Sell |
6,951,579
-330,130
| -5% | -$8.95M | 0.63% | 36 |
|
|
2024
Q3 | $211M | Buy |
7,281,709
+24,029
| +0.3% | +$701K | 0.68% | 35 |
|
|
2024
Q2 | $203M | Sell |
7,257,680
-412,765
| -5% | -$11.4M | 0.71% | 34 |
|
|
2024
Q1 | $213M | Buy |
7,670,445
+4,947,000
| +182% | +$137M | 0.73% | 35 |
|
|
2023
Q4 | $78.4M | Buy |
2,723,445
+4,315
| +0.2% | +$130K | 0.29% | 61 |
|
|
2023
Q3 | $90.2M | Sell |
2,719,130
-5,481
| -0.2% | -$194K | 0.39% | 54 |
|
|
2023
Q2 | $99.9M | Sell |
2,724,611
-17,238
| -0.6% | -$671K | 0.43% | 52 |
|
|
2023
Q1 | $112M | Sell |
2,741,849
-17,984
| -0.7% | -$777K | 0.48% | 47 |
|
|
2022
Q4 | $141M | Sell |
2,759,833
-109,519
| -4% | -$5.25M | 0.63% | 42 |
|
|
2022
Q3 | $126M | Sell |
2,869,352
-100,083
| -3% | -$4.86M | 0.62% | 41 |
|
|
2022
Q2 | $156M | Sell |
2,969,435
-427,993
| -13% | -$21.8M | 0.7% | 37 |
|
|
2022
Q1 | $176M | Sell |
3,397,428
-1,595,690
| -32% | -$82.8M | 0.67% | 41 |
|
|
2021
Q4 | $295M | Sell |
4,993,118
-28,776
| -0.6% | -$1.43M | 1.11% | 29 |
|
|
2021
Q3 | $216M | Buy |
5,021,894
+2,003,764
| +66% | +$88.8M | 0.86% | 36 |
|
|
2021
Q2 | $118M | Buy |
3,018,130
+118,931
| +4% | +$4.62M | 0.46% | 51 |
|
|
2021
Q1 | $105M | Buy |
2,899,199
+89,086
| +3% | +$3.16M | 0.43% | 54 |
|
|
2020
Q4 | $103M | Sell |
2,810,113
-73,562
| -3% | -$2.7M | 0.49% | 50 |
|
|
2020
Q3 | $100M | Buy |
2,883,675
+327,179
| +13% | +$11.5M | 0.63% | 47 |
|
|
2020
Q2 | $79.3M | Sell |
2,556,496
-761,604
| -23% | -$25.9M | 0.52% | 50 |
|
|
2020
Q1 | $103M | Sell |
3,318,100
-358
| -0% | -$12.2K | 0.78% | 41 |
|
|
2019
Q4 | $123M | Buy |
3,318,458
+330
| +0% | +$11.8K | 0.58% | 50 |
|
|
2019
Q3 | $113M | Sell |
3,318,128
-6,129
| -0.2% | -$223K | 0.62% | 49 |
|
|
2019
Q2 | $137M | Sell |
3,324,257
-41,382
| -1% | -$1.64M | 0.72% | 43 |
|
|
2019
Q1 | $136M | Sell |
3,365,639
-529,984
| -14% | -$21.2M | 0.74% | 43 |
|
|
2018
Q4 | $161M | Sell |
3,895,623
-782,482
| -17% | -$32.5M | 0.94% | 36 |
|
|
2018
Q3 | $196M | Sell |
4,678,105
-19,222
| -0.4% | -$740K | 0.95% | 39 |
|
|
2018
Q2 | $162M | Buy |
4,697,327
+93,989
| +2% | +$3.21M | 0.81% | 42 |
|
|
2018
Q1 | $155M | Buy |
4,603,338
+6,693
| +0.1% | +$230K | 0.79% | 41 |
|
|
2017
Q4 | $158M | Buy |
4,596,645
+371,924
| +9% | +$12.7M | 0.77% | 40 |
|
|
2017
Q3 | $143M | Buy |
4,224,721
+1,766,504
| +72% | +$56.8M | 0.76% | 41 |
|
|
2017
Q2 | $78.3M | Buy |
2,458,217
+120,963
| +5% | +$3.81M | 0.43% | 61 |
|
|
2017
Q1 | $75.9M | Hold |
2,337,254
| – | – | 0.43% | 62 |
|
|
2016
Q4 | $72M | Sell |
2,337,254
-118,182
| -5% | -$3.61M | 0.41% | 62 |
|
|
2016
Q3 | $78.9M | Buy |
2,455,436
+150,966
| +7% | +$5.05M | 0.48% | 56 |
|
|
2016
Q2 | $77M | Sell |
2,304,470
-738
| -0% | -$23.6K | 0.48% | 55 |
|
|
2016
Q1 | $64.8M | Buy |
2,305,208
+26,889
| +1% | +$768K | 0.4% | 62 |
|
|
2015
Q4 | $69.8M | Buy |
2,278,319
+1,871
| +0.1% | +$58.9K | 0.43% | 58 |
|
|
2015
Q3 | $67.8M | Hold |
2,276,448
| – | – | 0.43% | 55 |
|
|
2015
Q2 | $72.4M | Buy |
2,276,448
+211
| +0% | +$6.88K | 0.41% | 58 |
|
|
2015
Q1 | $75.1M | Sell |
2,276,237
-11,542
| -0.5% | -$367K | 0.42% | 57 |
|
|
2014
Q4 | $67.6M | Buy |
+2,287,779
| New | +$65.6M | 0.36% | 59 |
|
Other funds holding PFE
VCM
VPM
Pzena Investment Management's PFE Position: Q1 2026 in Review
Pzena Investment Management reduced its Pfizer (PFE) stake by 9.2% in Q1 2026, selling an estimated $16M and leaving 5,924,892 shares worth $166M. The position accounts for 0.54% of the portfolio, ranked #40.
Pzena Investment Management first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $295M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Pzena Investment Management held 5,924,892 shares of Pfizer worth $166M as of Q1 2026.
- Pzena Investment Management sold 601,908 Pfizer shares in Q1 2026, an estimated $16M.
- Pfizer made up 0.54% of Pzena Investment Management's portfolio in Q1 2026, its #40 holding.
- Pzena Investment Management first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
- Pzena Investment Management's Pfizer position peaked at $295M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Pzena Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.